Abstract
Atrial fibrillation (AF) is the most common arrhythmia. The European Society of Cardiology released a new version of the guideline to streamline AF-management and current studies highlight the importance of early treatment.Oral anticoagulation to prevent thromboembolic events remains essential in AF-management for patients at risk. NOAK therapy, if possible, is recommend as first line treatment. In general rhythm or rate control strategies are available. Symptomatic patients and patients with heart failure should be offered an early rhythm control. Catheter ablation is effective for rhythm control and and should be offered early in AF treatment additional to treatment of risk factors and comorbidities.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
